CClinicalTrials.gg
RecruitingNCT04704089COLOEMAILUpdated Jul 3, 2025

Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects

An observational study in Amelogenesis Imperfecta, Dental Fluoroses and Hypomineralization Molar Incisor, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 8 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-07-03.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
80
Ages
8 Years to 55 Years
Sex
All
01

Study summary

The study focuses on the analysis of enamel defects grouping together hypomineralization and hypoplasia. It focuses on 3 very characteristic enamel pathologies that are most often encountered in dental consultations: Molar Incisor Hypomineralization (MIH), dental fluorosis (FD) and amelogenesis imperfecta (AI). The research focuses on the use of a spectrophotometer for measuring tooth colors: the Zfx SpectroShade® (MHT) and its software as a means of early diagnosis of pre-eruptive enamel abnormalities. The main objective of the study is to analyze the color parameters of teeth affected with one of the 3 enamel abnormalities for use of the spectrophotometer as a non-invasive diagnostic tool for enamel defects.

The secondary objective is focused on the biological, structural and physicochemical characterizations of these different enamel pathologies from extracted teeth or enamel biopsies that must be ground to achieve a restoration.

Read the detailed description

Methodology:

V1 inclusion visit (D1):

The subjects will be screened during a consultation carried out as part of the treatment in the participating dentistry departments. The inclusion and non-inclusion criteria for participants will be verified and the study will be offered to eligible patients and controls. The research briefing note will be given and the non-objection of the participants (adults and representative (s) of parental authority) will be collected. The investigator will then take the photographs and spectrophotometer shots (at least 2 teeth per participant).

V2 follow-up visit (within 2 months of the inclusion visit (D2 to M2)):

The patients will be reviewed in consultation as part of the treatment for selective grinding for dental restoration or extraction (if the tooth (s) is (are) no longer storable). The teeth or pathological enamel samples will be recovered and centralized at the Laboratory of Oral Molecular Physiopathology.

Biological, structural and physico-chemical analyzes will be carried out from these samples.

In order to ensure follow-up of participants, the principal investigator of each center will maintain a correspondence table including the participant's identity and his research identification number. He will also keep a register of oppositions up to date.

The subject's opposition or participation will be notified in his medical file. A copy of the briefing notes and non-objection forms signed by the dentist will be kept on site with the research documents. Minors who become adults during their participation will benefit from appropriate information and their non-objection will be collected.

Primary endpoint Analysis, using the spectrophotometer, of the numerical values of the color of the teeth in each of the populations studied (Hereditary amelogenesis imperfecta (AIH), dental fluorosis (FD), Hypomineralization Incisors and Molar (MIH) and control).

For each pathology, the values of these parameters will be compared. Secondary endpoints

  • Intra-pathology classification according to the severity of each pathology.
  • Characterization and biological, structural and physicochemical analysis of these different pathologies from extracted teeth or enamel biopsy to be ground to achieve a restoration.

Sample analysis The teeth samples will be stored at room temperature in the Oral Molecular Physiopathology laboratory in the Research Center.

During the research, biological, structural and physicochemical analyzes will be carried out at the laboratory or in another laboratory in France or abroad. A contract will be established upstream of these analyzes with the partner laboratory.

At the end of the research, samples not destroyed by destructive analysis techniques will be embedded in the resin and stored for 10 years before being destroyed. These samples can be used for additional analyzes (biological, structural and physico-chemical) according to the request of the references for the publication process.

02

Conditions studied

  • Amelogenesis Imperfecta
  • Dental Fluoroses
  • Hypomineralization Molar Incisor

Keywords

  • Colorimetry (MeSH)
  • Amelogenesis Imperfecta (MeSH)
  • Dental Fluorosis (MeSH)
  • Molar-incisor-Hypomineralization (MeSH)
  • Developmental Enamel Defects (MeSH)
  • Shade selection
  • Dental color matching
  • Diagnosis (MeSH)
03

Who can participate

Ages eligible
8 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Major or minor patients with Hereditary Imperfect Amelogenesis Imperfecta (HIA), Dental Fluorosis (DF), Incisor and Molar Hypomineralization (MIH) or Control

Eligibility criteria

For patients :

Inclusion Criteria :

  1. Age between 8 and 55 years old
  2. Carrier of one of the following 3 quantitative pre-eruptive enamel anomalies : AIH, dental fluorosis or MIH
  3. Information and collection of the non-opposition of the adult patient or of the representative(s) of parental authority present for the minors.

Criteria for non-inclusion :

  1. Pregnant or breastfeeding woman
  2. Under guardianship or curators
  3. Opposition of the minor patient
  4. Presenting pre-eruptive anomalies only on the molars (the spectrophotometer can only take pictures of the anterior dental sector (incisors and canines)).
  5. Other types of hypomineralization (post-eruptive, of traumatic or infectious origin, idiopathic).
  6. Having undergone radiotherapy or chemotherapy inducing dental and periodontal damage.
  7. Having systemic abnormalities (unbalanced diseases), haemochromatosis, porphyria
  8. Under medication likely to disturb the coloring of the teeth

For witnesses :

Inclusion Criteria :

  1. Age between 8 and 55 years old
  2. Information and collection of the non-opposition of the adult witness or of the representative(s) of parental authority present for the minors.
  3. Free of any anomaly of tooth structure, exogenous dyschromia and carious lesions.

Criteria for non-inclusion :

  1. Pregnant or breastfeeding woman
  2. Under guardianship or curators
  3. Opposition of the minor witness
  4. Carrier of a quantitative pre-eruptive enamel anomaly
  5. Polycarpus (preventing the diagnosis of amyl hypomineralization)
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • spectrophotometer, and numerical values of tooth color in the populations studied

    at the first visit Shooting with Spectrophotometer and at the second visit for all patients except control population: Tooth extraction or restorative treatment Collection of teeth or enamel debris for analysis

    Other: spectrophotometer · Other: Biological (protein analysis by western blot or mass spectrometry of matrix proteins), structural (electron microscopy) and physico-chemical analyses

Interventions

  • Otherspectrophotometer

    * Calibration of the spectrophotometer (calibration of white and green color on the provided support), * Placing the patient or witness in the chair, * Placement of intraoral retractors, * Photographs of the dental arch in occlusion as well as slightly open mouth to visualize the mandibular incisors, * If MIH is suspected, occlusal images of the occlusal surfaces of the first molars will be taken with the help of a dental mirror, * Shooting with the spectrophotometer centered on each of the teeth of interest in the anterior sector with verification of the good quality of the shot according to the axis (validated in green on the camera), * Backup of images with coded identification number

  • OtherBiological (protein analysis by western blot or mass spectrometry of matrix proteins), structural (electron microscopy) and physico-chemical analyses

    * Chemical analysis of enamel mineral. * Techniques of spectrometry and spectroscopy (Raman and FTIR) * Atomic Probe Tomography and Protein Mass Spectrometry (ICP-MS).

05

What researchers measure

Primary outcomes

  1. analyze the color parameters of teeth presenting one of the 3 enamel anomalies in order to use the spectrophotometer as a non-invasive diagnostic tool for enamel dyschromia.

    Time frame: at the first visit = inclusion visit

Secondary outcomes

  1. Biological characterization of the proteins of the dental enamel matrix by Western Blot and/or mass spectrometry from samples (extracted teeth or enamel biopsies to be ground during the treatment).

    Time frame: at the second visit, 2 months after inclusion visit and after tooth extraction

  2. Ultra-structural characterization under electron microscope and biomechanics by nanoindentation of enamel pathologies from extracted teeth or enamel biopsies to be ground during the treatment.

    Time frame: at the second visit, 2 months after inclusion visit and after tooth extraction

  3. Physico-chemical characterization by different spectroscopic techniques of enamel pathologies from extracted teeth or enamel biopsies to be ground during the treatment.

    Time frame: at the second visit, 2 months after inclusion visit and after tooth extraction

  4. Physico-chemical characterization by atomic probe tomography of enamel pathologies from extracted teeth or enamel biopsies to be ground during the treatment.

    Time frame: at the second visit, 2 months after inclusion visit and after tooth extraction

06

Study locations

1 of 1 sites recruiting
  • Service d'odontologie, Hôpital Pitié-Salpêtrière
    Paris, 75013, France
    Recruiting
07

Registry details

Key details

Study ID
NCT04704089
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Jan 11, 2021
Start date
Jul 18, 2022
Primary completion
Apr 18, 2026 (estimated)
Completion
Apr 18, 2026 (estimated)
Last update
Jul 3, 2025

Study contacts

Sophia HOUARI, MCU-PH
Contact
sophia.houari@aphp.fr
06 12 16 88 35

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion